The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
rAAV-compatible MiniPromoters for restricted expression in the brain and eye
Open accessAbstract
BACKGROUND: Small promoters that recapitulate endogenous gene expression patterns are important for basic, preclinical, and now clinical research. Recently, there has been a promising revival of gene therapy for diseases with unmet therapeutic needs. To date, most gene therapies have used viral-based ubiquitous promoters-however, promoters that restrict expression to target cells will minimize off-target side effects, broaden the palette of deliverable therapeutics, and thereby improve safety and efficacy. Here, we take steps towards filling the need for such promoters by developing a high-throughput pipeline that goes from genome-based bioinformatic design to rapid testing in vivo. METHODS: For much of this work, therapeutically interesting Pleiades MiniPromoters (MiniPs; ~4 kb human DNA regulatory elements), previously tested in knock-in mice, were "cut down" to ~2.5 kb and tested in recombinant adeno-associated virus (rAAV), the virus of choice for gene therapy of the central nervous system. To evaluate our methods, we generated 29 experimental rAAV2/9 viruses carrying 19 different MiniPs, which were injected intravenously into neonatal mice to allow broad unbiased distribution, and characterized in neural tissues by X-gal immunohistochemistry for icre, or immunofluorescent detection of GFP. RESULTS: The data showed that 16 of the 19 (84 %) MiniPs recapitulated the expression pattern of their design source. This included expression of: Ple67 in brain raphe nuclei; Ple155 in Purkinje cells of the cerebellum, and retinal bipolar ON cells; Ple261 in endothelial cells of brain blood vessels; and Ple264 in retinal Müller glia. CONCLUSIONS: Overall, the methodology and MiniPs presented here represent important advances for basic and preclinical research, and may enable a paradigm shift in gene therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![Fig. 3 Eight MiniPromoters in rAAVs show unique expression related to their source gene when driving icre in mice carrying a “lox-stop-lox-lacZ” allele, an historical-indirect reporter. Each tEMS number indicates an individual animal. Ple94-icre (GPR88 RRs) expressed strongly in the striatum and in upper cortical layers. Ple198-icre (SLC6A4 RRs) expressed in the thalamus and shows a clear demarcation between LGd and LGv. Ple251-icre (C8ORF46 RRs) demonstrated strong expression in the hippocampus and cortex; layers IV, V, and Vb are predominant. The zona incerta is also labeled. Ple251-icre-WPRE (C8ORF48 RRs) extended the expression to most brain regions, particularly throughout the cortex and in the cerebellar granular layer. Ple266-icre (S100B RRs) expressed sporadically in the brain with puffy processes in the cortex and corpus callosum. As expected for partial viral transduction, a subset of GFAP+ astrocytes are co-labelled with β-gal. Ple267-icre (UGT8 RRs) has strong staining in the olfactory bulb and in the cerebellar granule layer, with some Purkinje cells labeled. In the OB, globeruli-like structures are stained. Ple303-icre (NOV RRs) stains all cortical layers in midline and becomes specific to cortical layer V in more lateral sections. Ple304-icre and Ple305-icre (both OLIG1 RRs) demonstrated an indistinguishable expression pattern with scattered cells in several brain regions, including the cortex and brainstem, resembling puffy processes of oligodendrocytes. Bs, brainstem; Cb, cerebellum; Ctx, cortex; Hipp, hippocampus; icre, improved cre recombinase; LGd, dorsal lateral geniculate; LGv, ventral lateral geniculate; Mb, midbrain; OB, olfactory bulb; RRs, regulatory regions; Str, striatum; Th, thalamus. Blue, β-gal positive; brown, DAB immunohistochemistry; red, neutral red. [Scale bars = 100 μm]](https://figures.cochat.ai/paper-figures/1118a627358c445db559ab7bf7be21f1/raav-compatible-minipromoters-for-restricted-expression-in-the-brain-and-eye-figure-3.jpg)
![Fig. 4 Two MiniPromoters selected based on icre expression, recapitulated their unique expression related to their source gene when tested driving EmGFP. Ple67-EmGFP ± WPRE (FEV RRs) drove expression in the dorsal raphe nuclei of the mouse brain. Ple155-EmGFP ± WPRE (PCP2 RRs) drove expression in the Purkinje cells of the cerebellum, similar to the endogenous gene. In both cases, the presence of WPRE enhanced the number of cells and intensity of cells showing expression. Cb, cerebellum; EmGFP, emerald green fluorescent protein; Raphe, raphe nuclei; RRs, regulatory regions; WPRE, woodchuck hepatitis virus post-transcriptional regulatory element. Blue, Hoechst 33342; Green, EmGFP immunofluorescence. [Scale bars = 200 μm]](https://figures.cochat.ai/paper-figures/3c383dd30cc14c83b5a665118bc61b00/raav-compatible-minipromoters-for-restricted-expression-in-the-brain-and-eye-figure-4.jpg)
![Fig. 5 Two CLDN5 RRs-based MiniPromoters (MiniPs) showed brain endothelial cell-specific expression related to their source gene, when virus was introduced into the adult circulatory system. a The Ple34 MiniP drove expression of the miniSOG fluorescent green reporter in blood vessels in the brain. Co-labelling was observed with CD31, a marker of endothelial cells. No miniSOG expression was detected in the heart where CD31 stains endocardial endothelium, or liver, where CD16/32 stains endothelial cells. b Ple261, a “cut down” of Ple34, also drove expression of EGFP in blood vessels in the brain. Again, co-labelling was observed with CD31, a marker of endothelial cells, but no expression was detected in the heart or liver. bp, base pairs; Ctx, cortex; EGFP, enhanced green fluorescent protein; miniSOG, mini Singlet Oxygen Generator; OB, olfactory bulb; RRs, regulatory regions. [Scale bars = 50 μm]](https://figures.cochat.ai/paper-figures/b44a3a10e2b7431fa2f2a8f484ff980b/raav-compatible-minipromoters-for-restricted-expression-in-the-brain-and-eye-figure-5.jpg)
![Fig. 6 Six MiniPromoters (MiniPs) showed cell type-specific expression in the retina. a The icre reporter led to identification of three retina positive MiniPs. Ple266-icre (S100B RRs) showed rare Müller glia expression as expected for the endogenous gene in one of two mice tested [69]. The astrocytic layer also demonstrated some staining. Ple302-icre (DCX RRs) intensely stained the ganglion cell layer (GCL), similar to previous DCX-based MiniPs [22]. For Ple303-icre (NOV RRs) we observed modest enrichment of staining in the outer side of the inner nuclear layer indicative of horizontal cells. Blue, β-gal positive; red, neutral red. b Constructs utilizing the EmGFP reporter identified an additional three MiniPs with retinal expression. In both cases tested, the presence of the WPRE enhanced the number and intensity of cells showing expression. Ple67-EmGFP ± WPRE (FEV RRs) demonstrated expression primarily in the GCL and inner nuclear layer in putative ganglion and amacrine cells. Rarely, additional cells were also positive with the WPRE-containing virus. Ple155-EmGFP ± WPRE (PCP2 RRs) restricted expression to bipolar ON cells. Ple264-EmGFP (NR2E1 RRs) showed strong staining of Müller glial cells. EmGFP, emerald green fluorescent protein; GCL, retinal ganglion cell layer; icre, improved cre recombinase; RRs, regulatory regions. [Scale bars = 100 μm]](https://figures.cochat.ai/paper-figures/a7c138aa986d4265bacfb60bca83e3f5/raav-compatible-minipromoters-for-restricted-expression-in-the-brain-and-eye-figure-6.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“systematic enhancer discovery has been accelerated by the recent development of technologies allowing for transcriptomic and epigenetic studies at single-cell resolution6–12.”
From Viral manipulation of functionally distinct interneurons in mice, non-human primates and humans (2020) · cites this paper as [9]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072
Genome-wide atlas of gene expression in the adult mouse brain
Lein, E. S., Hawrylycz, M. J., Ao, N., Ayres, M., Bensinger, A., Bernard, A., Boe, A. F., Boguski, M. S., Brockway, K. S., Byrnes, E. J., et al. (2007) · Nature · doi:10.1038/nature05453 · Cited by 5,572 · cited 1×
“expected by the endogenous gene expression in development and/or the adult mouse [45–49].”
BackgroundThe ENCODE (ENCyclopedia Of DNA Elements) Project
(2004) · Science · doi:10.1126/science.1105136 · Cited by 2,390
A User's Guide to the Encyclopedia of DNA Elements (ENCODE)
The ENCODE Project Consortium (2011) · PLoS Biology · doi:10.1371/journal.pbio.1001046 · Cited by 1,506
Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes
Foust, K. D., Nurre, E., Montgomery, C. L., Hernandez, A., Chan, C. M., & Kaspar, B. K. (2009) · Nature Biotechnology · doi:10.1038/nbt.1515 · Cited by 1,456 · cited 2×
“After an initial wide survey of methodologies, we focused on neo-natal intravenous delivery of singlestranded rAAV in AAV9, due to its excellent capability to transduce a variety of CNS cell types in our hands and as described in the literature [27, 40, 41].”
BackgroundMethodGene therapy returns to centre stage
Naldini, L. (2015) · Nature · doi:10.1038/nature15818 · Cited by 1,184
VISTA Enhancer Browser—a database of tissue-specific human enhancers
Visel, A., Minovitsky, S., Dubchak, I., & Pennacchio, L. A. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl822 · Cited by 1,080 · cited 3×
“Two were representative of the extensive community resource developed by the VISTA enhancer project, the main goal of which is to identify distant-acting noncoding regulatory elements that drive developmental gene expression in a region-specific manner [38].”
BackgroundMethodZufferey, R., Donello, J. E., Trono, D., & Hope, T. J. (1999) · Journal of Virology · doi:10.1128/jvi.73.4.2886-2892.1999 · Cited by 1,014 · cited 1×
“In this study we tested the 3’ UTR element WPRE (woodchuck hepatitis virus post-transcriptional regulatory element) mut6 [32, 33].”
MethodMathelier, A., Zhao, X., Zhang, A. W., Parcy, F., Worsley-Hunt, R., Arenillas, D. J., Buchman, S., Chen, C.-Y., Chou, A., Ienasescu, H., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt997 · Cited by 983 · cited 1×
“Now, as additional genome-wide datasets such as RNAseq, and new data and tools within projects such as FANTOM [30] and JASPAR [31] become publically available, they were exploited for bioinformatically-driven MiniP design and redesign.”
MethodSelf-citationCharting a course for genomic medicine from base pairs to bedside
National Human Genome Research Institute, Green, E. D., & Guyer, M. S. (2011) · Nature · doi:10.1038/nature09764 · Cited by 902 · cited 1×
“challenge [2, 19–21].”
Cited by
Chan, K. Y., Jang, M. J., Yoo, B. B., Greenbaum, A., Ravi, N., Wu, W.-L., Sánchez-Guardado, L., Lois, C., Mazmanian, S. K., Deverman, B. E., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4593 · Cited by 1,578
Miura, Y., Li, M.-Y., Birey, F., Ikeda, K., Revah, O., Thete, M. V., Park, J.-Y., Puno, A., Lee, S. H., Porteus, M. H., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-00763-w · Cited by 415
Systemic AAV vectors for widespread and targeted gene delivery in rodents
Challis, R. C., Ravindra Kumar, S., Chan, K. Y., Challis, C., Beadle, K., Jang, M. J., Kim, H. M., Rajendran, P. S., Tompkins, J. D., Shivkumar, K., et al. (2019) · Nature Protocols · doi:10.1038/s41596-018-0097-3 · Cited by 409
Gene therapy for neurological disorders: progress and prospects
Deverman, B. E., Ravina, B. M., Bankiewicz, K. S., Paul, S. M., & Sah, D. W. Y. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.110 · Cited by 306
Erratum: Gene therapy for neurological disorders: progress and prospects
Deverman, B. E., Ravina, B. M., Bankiewicz, K. S., Paul, S. M., & Sah, D. W. Y. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.158 · Cited by 248
Metadata
- Authors
- de Leeuw, C. N., Korecki, A. J., Berry, G. E., Hickmott, J. W., Lam, S. L., Lengyell, T. C., Bonaguro, R. J., Borretta, L. J., Chopra, V., Chou, A. Y., D’Souza, C. A., Kaspieva, O., Laprise, S., McInerny, S. C., Portales-Casamar, E., Swanson-Newman, M. I., Wong, K., Yang, G. S., Zhou, M., Jones, S. J. M., Holt, R. A., Asokan, A., Goldowitz, D., Wasserman, W. W., & Simpson, E. M.
- Affiliations
- University of British Columbia (CA)
- University of North Carolina at Chapel Hill (US)
- BC Cancer Agency (CA)
- Corresponding author
- Simpson, Elizabeth M.
- ORCID
- Venue
- Molecular Brain
- Published
- 2016-05-10
- Volume
- 9
- Issue
- 1
- Pages
- 52-52
- ISSN
- 1756-6606 (ISSN-L)
- PMC
- PMC4862195
- OpenAlex
- W2365630593
- Cited by
- 76
- References
- 71
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 6 · 2023: 9 · 2022: 12 · 2021: 5 · 2020: 7 · 2019: 11 · 2018: 7 · 2017: 4 · 2016: 3
- FWCI
- 6.72
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- Molecular Brain (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- cIRcle (University of British Columbia) (submittedVersion, cc-by)
- Spiral (Imperial College London) (submittedVersion, other-oa)
- Funders
- Genome British Columbia (AGCP-CanEuCre-01)
- Genome Canada
- GlaxoSmithKline
- BC Mental Health and Addiction Services
- Child and Family Research Institute
- University of British Columbia (UBC) Institute of Mental Health
- UBC Office of the Vice President Research
- NIH National Heart, Lung, and Blood Institute
- Brain Canada
- Quebec Consortium for Drug Discovery
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Keywords
- recombinant adeno-associated virus, AAV2/9, tissue-specific gene expression, central nervous system gene therapy, promoter design, raphe nuclei, Purkinje cells, retinal bipolar cells, Müller cells, brain endothelial cells, knock-in mice
- MeSH terms
- Dependovirus, Animals, Blood-Brain Barrier, Brain, Eye, Genetic Vectors, Mice, Inbred C57BL, Promoter Regions, Genetic, Recombination, Genetic, Transduction, Genetic, Gene Expression, Integrases, Retinal Bipolar Cells, Dorsal Raphe Nucleus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: rAAV-compatible MiniPromoters for restricted expression in the brain and eye. https://app.cochat.ai/papers/10.1186/s13041-016-0232-4
- The paper
- de Leeuw, C. N., Korecki, A. J., Berry, G. E., Hickmott, J. W., Lam, S. L., Lengyell, T. C., Bonaguro, R. J., Borretta, L. J., Chopra, V., Chou, A. Y., D’Souza, C. A., Kaspieva, O., Laprise, S., McInerny, S. C., Portales-Casamar, E., Swanson-Newman, M. I., Wong, K., Yang, G. S., Zhou, M., . . . Simpson, E. M. (2016). rAAV-compatible MiniPromoters for restricted expression in the brain and eye. Molecular Brain. https://doi.org/10.1186/s13041-016-0232-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.